MCM
AMTI

Moore Capital Management’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Moore Capital Management’s Portfolio AMTI Stock Details AMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100,000
Closed -$42K – 601
2022
Q4 		$42K Hold
100,000
– – ﹤0.01% 406
2022
Q3 		$97K Hold
100,000
– – ﹤0.01% 465
2022
Q2 		$291K Hold
100,000
– – 0.01% 444
2022
Q1 		$752K Hold
100,000
– – 0.02% 442
2021
Q4 		$1.4M Buy
+100,000
New +$1.97M 0.03% 436

Other funds holding AMTI

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Moore Capital Management's AMTI Position: Q1 2023 in Review

Moore Capital Management sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2023, closing a stake of 100,000 shares — an estimated $42K sold.

Moore Capital Management first reported a position in AMTI in Q4 2021 and held it in 5 quarters. The position peaked at $1.4M in Q4 2021. 35 funds tracked by Wall St. Rank hold AMTI as of Q1 2023.

  • Moore Capital Management reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Moore Capital Management sold 100,000 Applied Molecular Transport Inc. Common Stock shares in Q1 2023, an estimated $42K.
  • Moore Capital Management first reported a position in Applied Molecular Transport Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Moore Capital Management's Applied Molecular Transport Inc. Common Stock position peaked at $1.4M in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2023.

Based on Moore Capital Management's 13F filing for Q1 2023, filed 15 May 2023.